FUNI (Hypha Labs) Piotroski F-Score: 1 (As of Jun. 24, 2026) — 67% Below Median


What is Hypha Labs Piotroski F-Score?

Hypha Labs FUNI Piotroski F-Score is 1 as of Jun. 24, 2026, which is 67% below its 10-year median of 3.00. The stock has 2 warning signs investors should review. Among 211 Medical Diagnostics & Research companies, Hypha Labs ranks worse than 96.68% on this metric.

Warning Sign:

Piotroski F-Score of 1 is low, which usually implies poor business operation.

The zones of discrimination were as such:

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Hypha Labs has an F-score of 1. It is a bad or low score, which usually implies poor business operation.

The historical rank and industry rank for Hypha Labs's Piotroski F-Score or its related term are showing as below:

FUNI' s Piotroski F-Score Range Over the Past 10 Years
Min: 1   Med: 3   Max: 6
Current: 1

During the past 13 years, the highest Piotroski F-Score of Hypha Labs was 6. The lowest was 1. And the median was 3.

Hypha Labs  (OTCPK:FUNI) Piotroski F-Score Explanation

The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.

He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.

In 2000, he wrote a research paper called "Value Investing: The Use of Historical Financial Statement Information to Separate Winners from Losers" (pdf).

He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.

What he found was something that exceeded his most optimistic expectations.

Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.

Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).

Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.


Hypha Labs Piotroski F-Score Related Terms


Hypha Labs Piotroski F-Score Historical Data

* Premium members only.

The historical data trend for Hypha Labs's Piotroski F-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hypha Labs Piotroski F-Score Chart

Hypha Labs Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Piotroski F-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.00 3.00 5.00 1.00 2.00

Hypha Labs Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Piotroski F-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.00 2.00 2.00 2.00 1.00

FUNI vs IVRO, IDTA, NSTM: Piotroski F-Score Comparison

For the Diagnostics & Research subindustry, Hypha Labs's Piotroski F-Score, along with its competitors' market caps and Piotroski F-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Hypha Labs Piotroski F-Score vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Hypha Labs's Piotroski F-Score distribution charts can be found below:

* The bar in red indicates where Hypha Labs's Piotroski F-Score falls into.


How is the Piotroski F-Score calculated?

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar26) TTM:Last Year (Mar25) TTM:
Net Income was -0.562 + -0.558 + -0.522 + -0.521 = $-2.16 Mil.
Cash Flow from Operations was -0.023 + -0.315 + -0.15 + -0.051 = $-0.54 Mil.
Revenue was 0 + 0 + 0 + 0 = $0.00 Mil.
Gross Profit was 0 + 0 + 0 + 0 = $0.00 Mil.
Average Total Assets from the begining of this year (Mar25)
to the end of this year (Mar26) was
(0.257 + 0.454 + 0.409 + 0.392 + 0.16) / 5 = $0.3344 Mil.
Total Assets at the begining of this year (Mar25) was $0.26 Mil.
Long-Term Debt & Capital Lease Obligation was $1.51 Mil.
Total Current Assets was $0.10 Mil.
Total Current Liabilities was $1.44 Mil.
Net Income was -0.707 + -0.466 + -1.34 + -0.642 = $-3.16 Mil.

Revenue was 0 + 0 + 0 + 0 = $0.00 Mil.
Gross Profit was 0 + 0 + 0 + 0 = $0.00 Mil.
Average Total Assets from the begining of last year (Mar24)
to the end of last year (Mar25) was
(1.385 + 0.752 + 0.494 + 0.259 + 0.257) / 5 = $0.6294 Mil.
Total Assets at the begining of last year (Mar24) was $1.39 Mil.
Long-Term Debt & Capital Lease Obligation was $0.01 Mil.
Total Current Assets was $0.19 Mil.
Total Current Liabilities was $1.73 Mil.

*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.

Profitability

Question 1. Return on Assets (ROA)

Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Hypha Labs's current Net Income (TTM) was -2.16. ==> Negative ==> Score 0.

Question 2. Cash Flow Return on Assets (CFROA)

Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.

Score 1 if positive, 0 if negative.

Hypha Labs's current Cash Flow from Operations (TTM) was -0.54. ==> Negative ==> Score 0.

Question 3. Change in Return on Assets

Compare this year's return on assets (1) to last year's return on assets.

Score 1 if it's higher, 0 if it's lower.

ROA (This Year)=Net Income/Total Assets (Mar25)
=-2.163/0.257
=-8.41634241

ROA (Last Year)=Net Income/Total Assets (Mar24)
=-3.155/1.385
=-2.27797834

Hypha Labs's return on assets of this year was -8.41634241. Hypha Labs's return on assets of last year was -2.27797834. ==> Last year is higher ==> Score 0.

Question 4. Quality of Earnings (Accrual)

Compare Cash flow return on assets (2) to return on assets (1)

Score 1 if CFROA > ROA, 0 if CFROA <= ROA.

Hypha Labs's current Net Income (TTM) was -2.16. Hypha Labs's current Cash Flow from Operations (TTM) was -0.54. ==> -0.54 > -2.16 ==> CFROA > ROA ==> Score 1.

Funding

Question 5. Change in Gearing or Leverage

Compare this year's gearing (long-term debt divided by average total assets) to last year's gearing.

Score 0 if this year's gearing is higher, 1 otherwise.

Gearing (This Year: Mar26)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar25 to Mar26
=1.508/0.3344
=4.50956938

Gearing (Last Year: Mar25)=Long-Term Debt & Capital Lease Obligation/Average Total Assets from Mar24 to Mar25
=0.007/0.6294
=0.0111217

Hypha Labs's gearing of this year was 4.50956938. Hypha Labs's gearing of last year was 0.0111217. ==> Last year is lower than this year ==> Score 0.

Question 6. Change in Working Capital (Liquidity)

Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.

Score 1 if this year's current ratio is higher, 0 if it's lower

Current Ratio (This Year: Mar26)=Total Current Assets/Total Current Liabilities
=0.096/1.435
=0.06689895

Current Ratio (Last Year: Mar25)=Total Current Assets/Total Current Liabilities
=0.187/1.734
=0.10784314

Hypha Labs's current ratio of this year was 0.06689895. Hypha Labs's current ratio of last year was 0.10784314. ==> Last year's current ratio is higher ==> Score 0.

Question 7. Change in Shares in Issue

Compare the number of shares in issue this year, to the number in issue last year.

Score 0 if there is larger number of shares in issue this year, 1 otherwise.

Hypha Labs's number of shares in issue this year was 159.451. Hypha Labs's number of shares in issue last year was 131.082. ==> There is larger number of shares in issue this year. ==> Score 0.

Efficiency

Question 8. Change in Gross Margin

Compare this year's gross margin (Gross Profit divided by sales) to last year's.

Score 1 if this year's gross margin is higher, 0 if it's lower.

Gross Margin (This Year: TTM)=Gross Profit/Revenue
=0/0
=

Gross Margin (Last Year: TTM)=Gross Profit/Revenue
=0/0
=

Hypha Labs's gross margin of this year was . Hypha Labs's gross margin of last year was . ==> Last year's gross margin is higher ==> Score 0.

Question 9. Change in asset turnover

Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.

Score 1 if this year's asset turnover ratio is higher, 0 if it's lower

Asset Turnover (This Year)=Revenue/Total Assets at the Beginning of This Year (Mar25)
=0/0.257
=0

Asset Turnover (Last Year)=Revenue/Total Assets at the Beginning of Last Year (Mar24)
=0/1.385
=0

Hypha Labs's asset turnover of this year was 0. Hypha Labs's asset turnover of last year was 0. ==> Last year's asset turnover is higher ==> Score 0.

Evaluation

Piotroski F-Score= Que. 1+ Que. 2+ Que. 3+Que. 4+Que. 5+Que. 6+Que. 7+Que. 8+Que. 9
=0+0+0+1+0+0+0+0+0
=1

Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3

Hypha Labs has an F-score of 1. It is a bad or low score, which usually implies poor business operation.

Frequently Asked Questions Learn more about Piotroski F-Score →
What does a Piotroski F-Score of 1 mean?
Hypha Labs (FUNI) has a Piotroski F-Score of 1 as of Jun. 24, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Hypha Labs and its competitors. This is 67% below median its historical median of 3.00. Over the past decade, Hypha Labs' Piotroski F-Score has ranged from 1.00 to 6.00. According to the industry distribution chart, Hypha Labs ranks #204 out of 211 companies in the Medical Diagnostics & Research industry, placing it in the top 96.7%.
Is Hypha Labs' Piotroski F-Score too high?
Hypha Labs' current Piotroski F-Score of 1 is 67% below median its 10-year median of 3.00. Over the past 10 years, this metric has ranged from a low of 1.00 to a high of 6.00. The Medical Diagnostics & Research industry median Piotroski F-Score is 5.00. Hypha Labs' value of 1 is 80% below this industry median. Based on the distribution chart, Hypha Labs ranks #204 out of 211 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers.
How does Hypha Labs' Piotroski F-Score compare to IVRO and IDTA?
According to the Medical Diagnostics & Research industry distribution chart, Hypha Labs ranks #204 out of 211 companies for Piotroski F-Score. This places Hypha Labs in the lower half of its industry. The industry median Piotroski F-Score is 5.00. Hypha Labs' value of 1 is 80% below this benchmark. Historically, Hypha Labs' own Piotroski F-Score has ranged from 1.00 to 6.00 over the past decade. While the company's 10-year median is 3.00 vs. the industry median of 5.00, Hypha Labs has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Medical Diagnostics & Research company?
The median Piotroski F-Score among Medical Diagnostics & Research companies is 5.00, based on 211 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hypha Labs's current Piotroski F-Score of 1 is 80% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Hypha Labs and its competitors. For the Medical Diagnostics & Research industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hypha Labs's current Piotroski F-Score is 1, which is 67% below median its own 10-year median of 3.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hypha Labs stock overvalued right now?
Hypha Labs (FUNI) has a current Piotroski F-Score of 1. The current Piotroski F-Score is 1, which is 67% below median its 10-year median of 3.00 and 80% below the Medical Diagnostics & Research industry median of 5.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Hypha Labs (FUNI), the current Piotroski F-Score is 1 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Hypha Labs Business Description

Address 5940 S. Rainbow Boulevard, Las Vegas, NV, USA, 89118
Hypha Labs Inc engaged in the research, development, and commercialization of the Hypha Micropearl accelerator, an in-home, web-based, computer-controlled bioreactor designed to accelerate the production of nutritionally beneficial mushrooms for human consumption. The Company's easy-to-use device, together with replaceable cartridges ordered through its exclusive app, safely and effectively produced enriched mycelium of functional mushrooms, or Micropearls, in eight days. These Micropearls contained active mushroom ingredients in a concentrated, easy-to-handle, tasteless, and odorless form that could be incorporated into various foods and beverages without altering flavor.